[Hemodynamic and electrophysiologic changes in hypertrophic cardiomyopathy]

Area of Science:

• Cardiology
• Genetics
• Pathology

Background:

• Hypertrophic cardiomyopathy (HCM) is a primary disease of the heart muscle.
• It is characterized by abnormal thickening of the heart muscle, particularly the left ventricle.
• HCM can affect the heart's electrical system and valves, leading to various clinical presentations.

Purpose of the Study:

• To provide a comprehensive overview of the clinical manifestations of hypertrophic cardiomyopathy.
• To discuss the pathophysiology of obstructive and non-obstructive forms of HCM.
• To highlight the diagnostic challenges and prognostic implications of HCM.

Main Methods:

• Review of existing literature on hypertrophic cardiomyopathy.
• Analysis of clinical findings, including echocardiography, electrocardiography, and electrophysiology studies.
• Discussion of pathological mechanisms underlying HCM-related complications.

Main Results:

• The subaortic gradient, a dynamic obstruction, is a hallmark of obstructive HCM.
• Diastolic dysfunction is a primary driver of heart failure in HCM, often with preserved systolic function.
• Electrocardiogram abnormalities and rhythm disturbances, including atrial fibrillation, are highly prevalent.
• Mitral regurgitation is common, stemming from abnormal valve motion or structural changes.
• Coronary artery abnormalities can lead to myocardial infarction and systolic dysfunction.
• Sudden cardiac death is a risk, with multiple contributing mechanisms that are difficult to predict.

Conclusions:

• Hypertrophic cardiomyopathy presents with diverse and complex clinical features.
• Understanding the interplay of myocardial, valvular, and electrical abnormalities is crucial for patient management.
• Effective prediction and prevention of adverse outcomes, including sudden death, remain significant challenges in HCM.